Silence Therapeutics
Silence Therapeutics is a global biopharmaceutical company focused on the design and development of short interfering RNAs (siRNAs) to create precision engineered medicines for patients…
No open positions right now. Check back soon!
Browse all jobsAbout the company
Silence Therapeutics is a global biopharmaceutical company focused on the design and development of short interfering RNAs (siRNAs) to create precision engineered medicines for patients with limited or inadequate treatment options. The company is advancing a pipeline of siRNA therapeutics, including divesiran and zerlasiran, targeting diseases such as polycythemia vera and high Lp(a). With operations spanning drug discovery, clinical development, and commercialization, Silence Therapeutics has offices in London, Hoboken, and Berlin, and describes itself as a vibrant, growing global company with a start-up mindset.
Silence Therapeutics has a presence in Spain through its current open roles in clinical science, regulatory affairs, and quality assurance, indicating an expanding team in the region. The company emphasizes a collaborative culture and a commitment to patients, and it is recognized as a Great Place to Work®. For international professionals, the company offers opportunities to contribute to cutting-edge RNAi therapeutics in a global, diverse environment.
For International Professionals
- Silence Therapeutics has a global presence with offices in London (UK), Hoboken (USA), and Berlin (Germany), and is expanding its team in Spain.
- The company is a pioneer in siRNA therapeutics, with a pipeline including divesiran and zerlasiran for conditions like polycythemia vera and high Lp(a).
- Silence Therapeutics is certified as a Great Place to Work®, reflecting a positive workplace culture.
- Current roles in Spain include senior positions in clinical science, regulatory affairs, and quality assurance, indicating a focus on clinical development and compliance.
- The company emphasizes a global and diverse culture, spanning from drug discovery to clinical development and commercialization.
Company History
Silence Therapeutics is a biopharmaceutical company pioneering the design and development of short interfering RNAs (siRNAs) to create a new generation of precision engineered medicines. The company is advancing a pipeline of siRNA therapeutics, including divesiran and zerlasiran, targeting diseases with limited treatment options. With locations in London, Hoboken, and Berlin, the company operates globally across drug discovery, clinical development, and commercialization.